docetaxel anhydrous has been researched along with Nasopharyngeal Neoplasms in 97 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (13.40) | 29.6817 |
| 2010's | 68 (70.10) | 24.3611 |
| 2020's | 16 (16.49) | 2.80 |
| Authors | Studies |
|---|---|
| Fukugawa, Y; Matsuyama, T; Murakami, D; Nishimoto, K; Orita, Y; Oya, N; Saito, T; Toya, R; Watakabe, T | 1 |
| Chen, Q; Li, S | 1 |
| Dong, G; Li, G; Liu, H; Liu, T; Wang, G; Wu, X; Xu, L; Zhan, J | 1 |
| Bai, YH; Du, KP; He, F; Li, JF; Liu, H; Liu, R; Lu, ZQ; Shi, QY; Tao, HY; Wang, ZL; Zhang, JJ | 1 |
| Ahn, MJ; Algazi, AP; Aziz, MASA; Caguioa, PB; Chan, ATC; Cheng, A; Chong, WQ; Ho, C; Ho, GF; Hong, RL; Kho, SK; Kim, SB; Lee, VHF; Massarelli, E; Ng, QS; Ngamphaiboon, N; Ngan, RK; Saraf, S; Siu, LL; Soparattanapaisarn, N; Sriuranpong, V; Swaby, RF; Tiambeng, MLA; Yen, CJ; Yuan, J; Yun, T | 1 |
| Colevas, AD; Coty, J; Hara, W; Jun, M; Le, QT; Lira, R; Lu, R; McMillan, A; Pinto, H; Quon, A; Winters, E | 1 |
| Lian, CL; Wu, SG; Zhou, P; Zhou, R; Zhou, Y | 1 |
| Ai, P; Chen, N; Duan, B; Li, Y; Shi, H; Tian, J; Zhu, J | 1 |
| Cao, T; Fu, Y; Gao, Y; Li, X; Liu, Y; Peng, Y; Qi, X; Yin, L; Yuan, B; Zhang, S; Zhu, Q | 1 |
| Chen, D; Gao, J; Huang, C; Huang, H; Liang, J; Liu, M; Liu, W; Lu, Y; Luo, Z; Ning, X; Wang, R | 1 |
| Fan, WJ; Lu, YP; Luo, YR; Ma, L; Teng, F; Yu, W; Zhang, Q | 1 |
| Chen, XX; Gan, JY; Gong, XY; Jiang, H; Jin, F; Li, YY; Liu, KQ; Liu, LN; Long, JH; Luo, XL; Wu, WL; Zhou, JJ | 1 |
| Li, C; Luo, S; Shi, M; Wang, J; Xu, M; Zang, J; Zhao, L | 1 |
| Chen, K; Li, Y; Nong, S; Pan, X; Zhu, X | 1 |
| Honma, Y; Ikeda, A; Itami, J; Ito, K; Kashihara, T; Kato, K; Kobayashi, K; Kubo, Y; Matsumoto, F; Mori, T; Murakami, N; Oka, H; Omura, G; Takamizawa, S; Yamamoto, S; Yoshimoto, S | 1 |
| An, X; Feng, K; Li, S; Liao, H; Mei, T; Zhan, J; Zhao, C | 1 |
| Li, S; Shen, L | 1 |
| Liao, K; Qiu, WZ; Tao, HY; Yuan, YW; Zhan, ZJ; Zheng, RH | 1 |
| Hamauchi, S; Iida, Y; Kamijo, T; Kawahira, M; Nishimura, T; Ogawa, H; Onitsuka, T; Onoe, T; Onozawa, Y; Yasui, H; Yokota, T | 1 |
| Chen, L; Guo, R; Li, WF; Lin, AH; Liu, X; Ma, J; Mao, YP; Sun, Y; Tang, LL; Xu, C; Yang, SP; Zhang, Y; Zhou, GQ | 1 |
| Amoura, Z; Barbaud, A; Francès, C; Mathian, A; Monfort, JB; Senet, P | 1 |
| Hou, X; Jiang, G; Liu, T; Wang, Y; Wu, T; Wu, X; Xie, H; Xie, M | 1 |
| Alfonsi, M; Auperin, A; Blanchard, P; Bourhis, J; Cornely, A; Daoud, J; Elloumi, F; Frikha, M; Guigay, J; Lang, P; Moussa, A; Racadot, S; Sun, S; Tao, Y; Thariat, J; Toumi, N; Tuchais, C | 1 |
| He, X; Hu, C; Xue, F | 1 |
| Chan, LLK; Kam, MKM; Kwong, DLW; Lee, AWM; Lung, ML; Ng, WT; Ngan, RKC; Sze, HCK; Tung, SY; Yiu, HHY; Yuen, KT | 1 |
| Bouzguenda, R; Daoud, J; Fourati, N; Frikha, M; Ghorbel, A; Mnejja, W; Siala, W; Toumi, N | 1 |
| Chen, J; Chen, QQ; Liu, X; Peng, XH; Peng, XY; Qi, J; Tan, JJ; Wang, F; Yu, B; Zeng, FF | 1 |
| Hu, C; Li, Y; Lu, X; Qian, W; Xu, T | 1 |
| Chang, H; Deng, X; Ge, Y; Li, Y; Lu, L; OuYang, PY; Sheng, Y; Wu, JQ; Xie, T; Zhang, G | 1 |
| Li, N; Luo, J; Peng, X; Wei, Z; Zhang, Z | 1 |
| Chen, X; Liu, Y; Wang, Y; Zhang, T; Zhou, R; Zhu, J | 1 |
| Badheeb, AM; Bahannan, AA; Baothman, SY | 1 |
| Kwong, B; Tabata, MM | 1 |
| Chen, S; Li, G; Li, J; Liu, T; Lu, Z; Wu, X; Zhang, S | 1 |
| Chen, G; Dai, J; Wang, XY; Xie, CH; Zeng, L; Zhong, YH; Zhou, YF | 1 |
| Gu, K; Hu, QC; Wang, JP; Wu, YW; Zhai, XM; Zhang, JN | 1 |
| Guo, Y; Hu, C; Kong, L; Lu, JJ; Niu, X; Tham, IW; Zhang, Y | 1 |
| Chen, X; Chew, SC; Chowbay, B; Lee, EJ; Lim, J; Singh, O; Tan, EH | 1 |
| Bai, B; Cai, QC; Cai, QQ; Gao, Y; Huang, HQ; Wang, XX | 1 |
| Guo, CY; Han, SH; Song, HP; Yu, L; Zhang, PJ; Zhang, Z | 1 |
| Chen, J; Du, C; Hu, C; Jiang, J; Liu, C; Wang, X; Ying, H; Zhou, J | 1 |
| Chen, H; Hu, W; Huang, Z; Li, S; Wei, W; Xu, T; Zhang, G | 1 |
| Huang, SM; Li, JX; Lu, TX; Wen, BX | 1 |
| Hu, GQ; Hu, GY; Lin, JW; Liu, DB; Long, GX; Mei, Q; Yuan, XL; Zhou, XY | 1 |
| Chen, LK; Hu, ZH; Huang, Y; Liu, JL; Ma, Y; Ma, YX; Wei, CL; Wu, X; Xu, F; Xue, C; Zhang, J; Zhang, JW; Zhang, L; Zhao, HY; Zhao, LP; Zhao, YY; Zou, BY | 1 |
| Cheng, PJ; Li, P; Shan, GP; Zhang, L | 1 |
| Akin, S; Aksoy, S; Altundag, K; Babacan, T; Cengiz, M; Gullu, HI; Kertmen, N; Keskin, O; Sarici, F; Yazici, G | 1 |
| Dou, S; Guan, X; Li, F; Liu, Y; Xu, T; Zhu, G | 1 |
| Hanamoto, A; Honma, K; Inohara, H; Kitamura, K; Morii, E; Nakahara, S; Takenaka, Y; Yamamoto, Y; Yasui, T | 1 |
| Li, J; Liang, H; Pan, F; Pang, X; Ruan, Z; Zhang, Y; Zou, L | 1 |
| Chen, L; Guo, R; Li, WF; Lin, AH; Liu, X; Ma, J; Sun, Y; Zhang, F; Zhang, Y | 1 |
| Arai, Y; Komatsu, M; Nishimura, G; Oridate, N; Sakuma, Y; Sano, D; Shiono, O; Taguchi, T; Takahashi, M; Yabuki, K | 1 |
| Casanova, M; Errihani, H; Ferrari, A; Grzegorzewski, KJ; Orbach, D; Özyar, E; Pan, J; Patte, C; Shen, L; Varan, A; Veyrat-Follet, C; Zhang, L | 1 |
| Cheng, ZB; Liao, H; Lin, Z; Liu, YM; Lv, BJ; Peng, PJ; Tang, C; Wang, SY; Wang, ZH | 1 |
| Bi, T; Gong, X; He, Q; Jin, F; Li, Y; Li, Z; Long, J; Luo, X; Qu, B; Wu, W | 1 |
| Copson, B; Hayes, T; McLean, C; Pratap, U | 1 |
| Bonanno, L; Caminiti, F; Cammaroto, G; De Salvo, S; Galletti, B; Galletti, F; Mannella, VK; Santoro, R | 1 |
| Du, L; Ma, L; Wang, Q; Yang, S; Zhang, X; Zhao, F | 1 |
| Chen, J; Lin, S; Yang, S; Zhang, S | 1 |
| Jiang, G; Liu, F; Liu, T; Wang, W; Wang, Y; Wu, T; Wu, X; Xie, M; Zhang, T | 1 |
| Ai, P; Gong, FM; Hu, X; Peng, X; Ren, M; Tang, J; Wu, S | 1 |
| Bei, JX; Cao, KJ; Chen, MY; Chen, QY; Guo, L; Guo, SS; Guo, X; Hong, MH; Liu, LT; Liu, XW; Ma, J; Mai, HQ; Mo, HY; Qian, CN; Shao, JY; Sun, Y; Tang, LQ; Xie, CM; Zeng, MS; Zhang, L; Zhao, C | 1 |
| Ai, J; Hou, M; Li, W; Liu, H; Tan, G; Xie, Z; Zeng, R | 1 |
| Alfieri, S; Bergamini, C; Bossi, P; Cavallo, A; Cova, A; Granata, R; Huber, V; Iacovelli, NA; Imbimbo, M; Licitra, L; Locati, L; Mariani, L; Miceli, R; Orlandi, E; Resteghini, C; Rivoltini, L | 1 |
| Blanchard, P; De Felice, F; Deutsch, E; El Khoury, C; Even, C; Gorphe, P; Janot, F; Levy, A; Nguyen, F; Ou, D; Tao, Y; Temam, S | 1 |
| Jiang, W; Luo, S; Pan, H; Shi, M; Wang, J; Xu, M; Zang, J; Zhao, L; Zhou, Y | 1 |
| Chen, L; Ma, J; Mao, YP; Sun, Y; Tang, LL; Yao, JJ; Yu, XL; Zhang, F; Zhang, WJ; Zhou, GQ | 1 |
| Akyüz, C; Aydin, B; Büyükpamukçu, M; Corapçioğlu, F; Köksal, Y; Ozyar, E; Varan, A; Yazici, N | 1 |
| Bu, Q; Cai, QQ; Guan, ZZ; Hu, XH; Huang, HQ; Li, YH; Lin, XB; Pan, ZH; Shuang, YR; Wang, AL | 1 |
| Ahuja, AT; Chan, AT; Chan, I; Chiu, SK; Ho, R; Hui, EP; Kam, MK; King, AD; Kwan, WH; Leung, SF; Ma, BB; Mo, F; Yu, BK; Zee, BC | 1 |
| Bossi, P; Cantù, G; Franceschini, M; Guzzo, M; Licitra, L; Olmi, P; Orlandi, E; Palazzi, M; Pignoli, E; Potepan, P; Scaramellini, G; Tomatis, S | 1 |
| Hu, WH; Li, JS; Peng, M; Qi, SN; Xie, FY; Zou, GR | 2 |
| Bae, WK; Cho, SH; Chung, IJ; Chung, WK; Hwang, JE; Lee, JK; Lim, SC; Shim, HJ | 1 |
| Esmat, E; Galal, K; Hassan, E | 1 |
| Chen, QY; Guo, L; Huang, PY; Lin, HX; Wang, CT; Xu, M | 1 |
| Chen, QY; Guo, X; Hong, MH; Lu, X; Xiang, YQ; Zeng, Q | 1 |
| Chen, H; Lin, JR; Xie, B; Xu, ZY; Zhang, WM; Zheng, JH; Zhou, J | 1 |
| Chan, AT; Cheng, SH; Cheung, CS; Ho, K; Hui, EP; Lau, CP; Lui, VW; Ma, BB; Ng, MH; Wong, CS | 1 |
| Ang, MK; Chowbay, B; Gao, F; Leong, SS; Lim, WT; Ngeow, J; Tan, EH; Toh, CK | 1 |
| Huang, Q; Li, DJ; Lu, MQ; Ren, JH; Su, J; Wu, YP; Xu, XH; Xue, F; Yi, F | 1 |
| Bergamini, C; Bossi, P; Fallai, C; Franceschini, M; Gloghini, A; Granata, R; Licitra, L; Locati, LD; Mattana, F; Miceli, R; Mirabile, A; Olmi, P; Orlandi, E; Parolini, D; Potepan, P; Quattrone, P; Scaramellini, G | 1 |
| Chen, X; Chew, SC; Chowbay, B; Kulkarni, T; Lee, EJ; Lim, WT; Ramasamy, RD; Singh, O; Tan, EH | 1 |
| Altun, M; Aslan, I; Basaran, M; Bavbek, SE; Ekenel, M; Keskin, S; Meral, R; Ozdemir, C | 1 |
| Chen, SZ; Chen, XM; Ding, Y; Mo, KL; Wang, XC; Zhang, F | 1 |
| Chen, X; Chew, SC; Chowbay, B; Lee, EJ; Lim, WT; Sandanaraj, E; Singh, O; Tan, EH | 1 |
| Fu, X; Hsia, Y; Li, J; Long, X; Luo, S; Shi, M; Wang, J; Xiao, F; Xu, M; Zhao, L; Zhou, B | 1 |
| Hirama, M; Horiuchi, C; Ishitoya, J; Komatsu, M; Matsuda, H; Mori, M; Niho, T; Nishimura, G; Sakuma, Y; Shiono, O; Taguch, T; Takahashi, M; Tsukuda, M | 1 |
| Guan, XY; Liu, YJ; Zhu, GP | 1 |
| Du, C; Hu, C; Ying, H; Zhang, Y; Zhou, J | 1 |
| Cai, XY; Deng, YM; Feng, WN; Huang, ZL; Lin, L; Lu, QX; Wei, WH; Wu, YF; Xu, T; Zhang, GY | 1 |
| Ahn, MJ; Cho, IS; Heo, DS; Hwang, DW; Jang, JS; Ji, JH; Kang, JH; Kim, SB; Park, JC; Park, K; Shin, SW; Sohn, CH; Sun, JM; Yun, T | 1 |
| Degendorfer, P; Furlan, M; McCarthy, JS; Panzarella, T; Siu, LL; Tannock, IF | 1 |
| Brumfield, B; Clayman, G; Diaz, EM; Garden, A; Glisson, BS; Johnson, FM; Khuri, FR; Kies, M; Morrison, W; Palmer, JL; Papadimitrakopoulou, V | 1 |
| Au, GK; Chua, DT; Sham, JS | 1 |
| Akagi, H; Kariya, S; Kosaka, M; Nishizaki, K; Orita, Y | 1 |
| Akmansu, M; Benekli, M; Bora, H; Buyukberber, S; Coskun, U; Kaya, AO; Ozturk, B; Pak, Y; Uner, A; Unsal, D; Yamac, D; Yaman, E; Yildiz, R | 1 |
3 review(s) available for docetaxel anhydrous and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Cisplatin; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Survival Analysis | 2020 |
[A Case of Nasopharyngeal Cancer with Febrile Neutropenia Followed by Death during Adjuvant Chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Autopsy; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Colitis; Docetaxel; Fatal Outcome; Febrile Neutropenia; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nasopharyngeal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Staphylococcal Infections; Taxoids | 2015 |
A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hematologic Diseases; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neutropenia; Survival Analysis; Taxoids; Treatment Outcome | 2005 |
35 trial(s) available for docetaxel anhydrous and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Nasopharyngeal Neoplasms; Platinum | 2023 |
Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter rando
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Drug Tolerance; Female; Fluorouracil; Humans; Induction Chemotherapy; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Young Adult | 2019 |
Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Diffusion Magnetic Resonance Imaging; Docetaxel; Female; Follow-Up Studies; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Prospective Studies; Radiation Injuries; Radiotherapy, Intensity-Modulated; Salivary Glands; Salivation; Xerostomia; Young Adult | 2020 |
[Analysis of follow-up results of chrono-chemotherapy or conventional chemotherapy combined with intensity modulated radiotherapy in locally advanced nasopharyngeal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Chronotherapy; Fluorouracil; Follow-Up Studies; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiotherapy, Intensity-Modulated; Treatment Outcome | 2020 |
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2018 |
Impact of minimum point dose on local control and toxicity in T3-4 nasopharyngeal carcinoma treated with intensity-modulated radiation therapy plus chemotherapy.
Topics: Adult; Aged; Carcinoma; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Fluorouracil; Humans; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Prognosis; Radiotherapy, Intensity-Modulated; Survival Analysis; Taxoids; Treatment Outcome; Tumor Burden; Young Adult | 2018 |
Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cetuximab; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Neoplasm Recurrence, Local; Progression-Free Survival; Prospective Studies; Radiotherapy, Intensity-Modulated; Salvage Therapy; Temporal Lobe; Treatment Outcome | 2018 |
Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Radiotherapy, Intensity-Modulated; Taxoids; Young Adult | 2013 |
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Prospective Studies; Radiotherapy, Conformal; Survival Rate; Taxoids | 2013 |
Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Asian People; Carcinoma; Constitutive Androstane Receptor; Docetaxel; Female; Haplotypes; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platelet Count; Polymorphism, Single Nucleotide; Receptors, Cytoplasmic and Nuclear; Taxoids | 2014 |
Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Cisplatin; Deoxycytidine; Disease-Free Survival; DNA, Viral; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Taxoids; Treatment Outcome; Young Adult | 2014 |
[Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mucositis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Intensity-Modulated; Remission Induction; Survival Rate; Taxoids; Vinblastine; Vinorelbine; Young Adult | 2013 |
Single-arm, multi-centre phase II study of lobaplatin combined with docetaxel for recurrent and metastatic nasopharyngeal carcinoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclobutanes; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Organoplatinum Compounds; Recurrence; Survival Rate; Taxoids | 2014 |
Phase I dose-escalation study of aflibercept plus docetaxel in nasopharyngeal carcinoma and other solid tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carcinoma; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Radiography; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids; Vascular Endothelial Growth Factor A | 2014 |
The role of concurrent chemotherapy to intensity-modulated radiotherapy (IMRT) after neoadjuvant docetaxel and cisplatin treatment in locoregionally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Prognosis; Radiotherapy, Intensity-Modulated; Taxoids; Treatment Outcome; Young Adult | 2015 |
Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study.
Topics: Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Quality of Life; Radiotherapy, Intensity-Modulated; Stomatitis; Taxoids; Treatment Outcome; Young Adult | 2015 |
Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Nasopharyngeal Carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Retrospective Studies; Taxoids; Young Adult | 2015 |
International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Child; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Taxoids; Treatment Outcome | 2016 |
Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Docetaxel; Drug Design; Female; Humans; Injections, Intravenous; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organoplatinum Compounds; Taxoids; Young Adult | 2015 |
[Phase II clinical trial of two different modes of administration of the induction chemotherapy for locally advanced nasopharyngeal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Drug Chronotherapy; Fluorouracil; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nausea; Neoplasm Staging; Radiotherapy, Intensity-Modulated; Taxoids; Treatment Outcome | 2015 |
A Phase II Clinical Trial of Concurrent Helical Tomotherapy plus Cetuximab Followed by Adjuvant Chemotherapy with Cisplatin and Docetaxel for Locally Advanced Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cetuximab; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Taxoids; Young Adult | 2016 |
An open-label, single-arm phase II clinical study of docetaxel plus lobaplatin for Chinese patients with pulmonary and hepatic metastasis of nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyclobutanes; Docetaxel; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Taxoids | 2016 |
[Preliminary result of multi-center clinical trial on the docetaxel, 5-Fu and DDP in the treatment of advanced, recurrent or metastatic nasopharyngeal carcinoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Nasopharyngeal Neoplasms; Nausea; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Taxoids; Young Adult | 2008 |
Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Quality of Life; Survival Rate; Taxoids; Treatment Outcome | 2009 |
[Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Middle Aged; Mucositis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutropenia; Prospective Studies; Remission Induction; Taxoids; Young Adult | 2009 |
Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mucositis; Nasopharyngeal Neoplasms; Nausea; Neoplasm Staging; Neutropenia; Taxoids; Treatment Outcome | 2010 |
Phase I study of TPF neoadjuvant chemotherapy followed by radical radiotherapy in advanced nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Mucositis; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Radiotherapy, High-Energy; Taxoids | 2010 |
Comparison of the short-term efficacy of two inductive chemotherapy regimens for locally advanced nasopharyngeal caricinoma: docetaxal plus carboplatin versus 5-fluorouracil plus carboplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutropenia; Survival Rate; Taxoids; Thrombocytopenia; Vomiting | 2010 |
Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Disease-Free Survival; Docetaxel; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Palliative Care; Quality of Life; Taxoids; Treatment Failure | 2011 |
The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.
Topics: Antineoplastic Agents; Asian People; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cytochrome P-450 CYP3A; Docetaxel; Female; Humans; Male; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Nasopharyngeal Neoplasms; Neoplasm Proteins; Organic Anion Transporters, Sodium-Independent; Polymorphism, Single Nucleotide; Solute Carrier Organic Anion Transporter Family Member 1B3; Taxoids | 2011 |
A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Taxoids | 2012 |
A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Taxoids; Treatment Outcome | 2002 |
A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status.
Topics: Adult; Aged; Carboplatin; Carcinoma; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Risk Assessment; Survival Analysis; Taxoids; Treatment Outcome | 2004 |
A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hematologic Diseases; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neutropenia; Survival Analysis; Taxoids; Treatment Outcome | 2005 |
[Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Particle Accelerators; Radiotherapy, High-Energy; Stomatitis; Taxoids | 2007 |
60 other study(ies) available for docetaxel anhydrous and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil for T3 N0 Glottic Carcinoma Without Vocal Cord Fixation.
Topics: Adult; Aged; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Vocal Cords | 2022 |
Gemcitabine Versus Docetaxel Plus Cisplatin as Induction Chemotherapy in Nasopharyngeal Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Gemcitabine; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Retrospective Studies | 2022 |
Effects of combination docetaxel with NO treatment to enhance the anti-nasopharyngeal carcinoma efficiency in vitro and in vivo.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Docetaxel; Humans; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Xenograft Model Antitumor Assays | 2022 |
Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Experiences of two centers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Humans; Induction Chemotherapy; Maintenance Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2023 |
In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platinum | 2023 |
Assessment of Response to Different Induction Chemotherapy Regimens in Locally Advanced Nasopharyngeal Carcinoma.
Topics: Cisplatin; Docetaxel; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2023 |
Comparison of GP and TPF induction chemotherapy for locally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Gemcitabine; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Survival Rate; Taxoids; Treatment Outcome; Young Adult | 2019 |
USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis.
Topics: Apoptosis; Cell Cycle Proteins; Chromosomes; Chromosomes, Human; Docetaxel; Drug Resistance, Neoplasm; G2 Phase Cell Cycle Checkpoints; HEK293 Cells; Humans; M Phase Cell Cycle Checkpoints; Male; Mitosis; Nasopharyngeal Neoplasms; Polo-Like Kinase 1; Prostatic Neoplasms; Protease Inhibitors; Protein Serine-Threonine Kinases; Protein Stability; Proto-Oncogene Proteins; Signal Transduction; Thiophenes; Transfection; Ubiquitin-Specific Peptidase 7 | 2019 |
Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; China; Cisplatin; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Treatment Outcome | 2020 |
Therapeutic Effect of Chemotherapy Cycle in Nasopharyngeal Carcinoma (NPC) Patients Who Developed Bone-Only Metastasis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemoradiotherapy; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Prognosis; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate | 2020 |
Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Pilot Projects; Progression-Free Survival; Retrospective Studies; Young Adult | 2021 |
Docetaxel exposure and hematological toxicity in Chinese patients with locally advanced/metastatic nasopharyngeal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; China; Docetaxel; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Taxoids | 2021 |
The change in tumor volume after induction chemotherapy with docetaxel plus cisplatin in 259 nasopharyngeal carcinoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Retrospective Studies; Tumor Burden | 2021 |
Docetaxel and cisplatin induction chemotherapy with or without fluorouracil in locoregionally advanced nasopharyngeal carcinoma: A retrospective propensity score matching analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Propensity Score; Retrospective Studies | 2022 |
Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal Stage N2-3.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Retrospective Studies; Survival Analysis; Taxoids | 2017 |
Neutropenia during the First Cycle of Induction Chemotherapy Is Prognostic for Poor Survival in Locoregionally Advanced Nasopharyngeal Carcinoma: A Real-World Study in an Endemic Area.
Topics: Adult; Carcinoma; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutropenia; Prognosis; Survival Analysis; Taxoids; Young Adult | 2018 |
[Cancers associated with systemic sclerosis involving anti-RNA polymerase III antibodies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Autoantigens; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiotherapy, Adjuvant; Raynaud Disease; Remission Induction; RNA Polymerase III; Scleroderma, Systemic; Taxoids; Tonsillectomy; Young Adult | 2018 |
CD-PLLD co-delivering docetaxel and MMP-9 siRNA plasmid for nasopharyngeal carcinoma therapy in vivo.
Topics: Animals; beta-Cyclodextrins; Carcinoma; Cell Line, Tumor; Docetaxel; Drug Carriers; Humans; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Polylysine; Proliferating Cell Nuclear Antigen; RNA, Small Interfering; Taxoids; Transplantation, Heterologous | 2017 |
[Neoadjuvant chemotherapy with concurrent chemoradiotherapy in the treatment of nasopharyngeal cancer: Southern Tunisian experience].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neutropenia; Radiotherapy Dosage; Retrospective Studies; Taxoids; Tunisia | 2018 |
A Retrospective Study to Compare Five Induction Chemotherapy Regimens Prior to Radiotherapy in the Reduction of Regional Lymph Node Size in Patients with Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Carcinoma; Chemoradiotherapy; China; Cisplatin; Disease-Free Survival; Docetaxel; Endostatins; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy; Retrospective Studies; Taxoids | 2018 |
Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Dose-Response Relationship, Radiation; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Diseases; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, High-Energy; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome; Ulcer | 2018 |
Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Edema; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Incidence; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Temporal Lobe | 2018 |
Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Cohort Studies; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Descriptive Study of Nasopharyngeal Carcinoma and Treatment Outcomes: An Eight Years Experience in Hadhramout National Cancer Centre, Yemen.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Prognosis; Radiotherapy, Conformal; Registries; Survival Rate; Yemen; Young Adult | 2019 |
Periorbital dermatitis in patients receiving docetaxel in combination chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cetuximab; Cisplatin; Docetaxel; Drug Eruptions; Facial Dermatoses; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Nivolumab; Parotid Neoplasms; Skull Base Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2019 |
Transferrin-targeting redox hyperbranched poly(amido amine)-functionalized graphene oxide for sensitized chemotherapy combined with gene therapy to nasopharyngeal carcinoma.
Topics: 3T3 Cells; Amines; Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Docetaxel; Drug Carriers; Drug Delivery Systems; Gene Transfer Techniques; Genetic Therapy; Glutathione; Graphite; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; RNA, Small Interfering; Transferrin | 2019 |
Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carcinoma; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; DNA-Binding Proteins; Docetaxel; Female; Genotype; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Polymorphism, Single Nucleotide; Radiation Tolerance; Taxoids; Treatment Outcome; X-ray Repair Cross Complementing Protein 1 | 2016 |
Prediction of the response to docetaxel-based chemotherapy for locoregionally advanced nasopharyngeal carcinoma: the role of double-phase (99m)Tc-MIBI SPECT/CT.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Prospective Studies; Radiopharmaceuticals; Taxoids; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2014 |
Pretreatment Epstein-Barr virus DNA load and cumulative cisplatin dose intensity affect long-term outcome of nasopharyngeal carcinoma treated with concurrent chemotherapy: experience of an institute in an endemic area.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; China; Cisplatin; DNA, Viral; Docetaxel; Dose-Response Relationship, Drug; Endemic Diseases; Female; Herpesvirus 4, Human; Humans; Longitudinal Studies; Male; Middle Aged; Nasopharyngeal Neoplasms; Prevalence; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome; Viral Load; Young Adult | 2014 |
Prognostic factors on overall survival of newly diagnosed metastatic nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Neck; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Radiotherapy, Conformal; Survival Rate; Taxoids; Young Adult | 2014 |
Comparison of three different induction regimens for nasopharyngeal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Neoplasms; Remission Induction; Retrospective Studies; Taxoids; Young Adult | 2015 |
Radiotherapy combined docetaxel and oxaliplatin chemotherapy is effective in patients with locally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Docetaxel; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Oxaliplatin; Survival Rate; Taxoids; Treatment Outcome; Young Adult | 2015 |
Efficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma; Case-Control Studies; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Gamma Rays; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Organoplatinum Compounds; Prognosis; Risk; Survival Analysis; Taxoids; Treatment Outcome | 2015 |
Nasopharyngeal metastasis of breast carcinoma with HER 2 discordance: a case report.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Molecular Targeted Therapy; Nasal Obstruction; Nasopharyngeal Neoplasms; Rare Diseases; Receptor, ErbB-2; Tomography, X-Ray Computed; Trastuzumab; Treatment Outcome | 2018 |
Olfactory event-related potentials: a new approach for the evaluation of olfaction in nasopharyngeal carcinoma patients treated with chemo-radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Evoked Potentials; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Olfaction Disorders; Radiotherapy, Intensity-Modulated; Smell; Surveys and Questionnaires; Taxoids | 2016 |
Folate-targeted star-shaped cationic copolymer co-delivering docetaxel and MMP-9 siRNA for nasopharyngeal carcinoma therapy.
Topics: Animals; Apoptosis; beta-Cyclodextrins; Carcinoma; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Female; Folic Acid; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Spectroscopy; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Polylysine; Proliferating Cell Nuclear Antigen; RNA, Small Interfering; Taxoids; Tissue Distribution; Transfection | 2016 |
Proteomic analysis of docetaxel resistance in human nasopharyngeal carcinoma cells using the two-dimensional gel electrophoresis method.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphopyruvate Hydratase; Proteomics; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Taxoids | 2016 |
Advanced-Stage Nasopharyngeal Carcinoma: Restaging System after Neoadjuvant Chemotherapy on the Basis of MR Imaging Determines Survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Prospective Studies; Radiotherapy, Intensity-Modulated; Survival Rate; Taxoids; Treatment Outcome | 2017 |
Blockage of SSRP1/Ets-1/Pim-3 signalling enhances chemosensitivity of nasopharyngeal carcinoma to docetaxel in vitro.
Topics: Autophagy; Carcinoma; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Docetaxel; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; High Mobility Group Proteins; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasm Invasiveness; Protein Serine-Threonine Kinases; Proto-Oncogene Protein c-ets-1; Proto-Oncogene Proteins; Signal Transduction; Taxoids; Transcriptional Elongation Factors | 2016 |
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cytokines; Docetaxel; Dose Fractionation, Radiation; Fluorouracil; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Interleukin-1beta; Interleukin-6; Laryngeal Neoplasms; Mouth Neoplasms; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies; Radiotherapy, Intensity-Modulated; Saliva; Severity of Illness Index; Stomatitis; Taxoids; Time Factors; Tumor Necrosis Factor-alpha | 2016 |
Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Prognosis; Taxoids | 2016 |
Induction chemotherapy for the treatment of non-endemic locally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Deoxycytidine; Disease Progression; Disease-Free Survival; Docetaxel; Female; Gemcitabine; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Retrospective Studies; Risk Factors; Taxoids; Time Factors; Treatment Outcome; Young Adult | 2017 |
Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Prognosis; Taxoids; Treatment Outcome; Young Adult | 2017 |
Pediatric and young adult nasopharyngeal carcinoma patients treated with preradiation Cisplatin and docetaxel chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; DNA, Viral; Docetaxel; Drug Administration Schedule; Female; Herpesvirus 4, Human; Humans; Male; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Survival Analysis; Taxoids; Young Adult | 2009 |
Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Italy; Male; Middle Aged; Nasopharyngeal Neoplasms; Prospective Studies; Radiotherapy, Intensity-Modulated; Remission Induction; Taxoids; Treatment Outcome; Young Adult | 2009 |
Neo-adjuvant Docetaxel and Cisplatin followed by concurrent Cisplatin with radiation therapy in treatment of locally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Feasibility Studies; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Taxoids; Treatment Outcome | 2008 |
[Analysis of responses and prognostic factors in different chemotherapy regimens for metastatic nasopharyngeal carcinoma: a report of 171 cases].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Proportional Hazards Models; Remission Induction; Retrospective Studies; Survival Rate; Taxoids; Young Adult | 2009 |
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Indoles; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Taxoids; Xenograft Model Antitumor Assays | 2011 |
Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma; Cell Differentiation; Cell Line; Cell Separation; Cisplatin; Docetaxel; Humans; Hyaluronan Receptors; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplastic Stem Cells; Taxoids | 2011 |
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Epstein-Barr Virus Infections; Female; Fluorouracil; Humans; Induction Chemotherapy; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Taxoids | 2011 |
Induction chemotherapy with docetaxel and cisplatin is highly effective for locally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Remission Induction; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Young Adult | 2011 |
Combined chemotherapy with cisplatin, docetaxel and capecitabine for metastatic nasopharyngeal carcinoma: a retrospective analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Retrospective Studies; Taxoids | 2011 |
Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Asian People; Docetaxel; Female; Haplotypes; Humans; Linkage Disequilibrium; Male; Metabolic Clearance Rate; Middle Aged; Nasopharyngeal Neoplasms; Organic Anion Transporters, Sodium-Independent; Pharmacogenetics; Polymorphism, Single Nucleotide; Solute Carrier Organic Anion Transporter Family Member 1B3; Taxoids | 2012 |
Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child; Cisplatin; Docetaxel; Dose-Response Relationship, Radiation; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Taxoids; Treatment Failure; Young Adult | 2012 |
Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Leucovorin; Male; Methotrexate; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Retrospective Studies; Taxoids | 2012 |
Comparison of the NCI-CTCAE version 4.0 and version 3.0 in assessing chemoradiation-induced oral mucositis for locally advanced nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Quality of Life; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy, Intensity-Modulated; Reproducibility of Results; Severity of Illness Index; Stomatitis; Surveys and Questionnaires; Taxoids; Treatment Outcome | 2012 |
Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Intensity-Modulated; Taxoids; Treatment Outcome | 2013 |
Concurrent weekly docetaxel chemotherapy in combination with radiotherapy for stage III and IVA-B nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carcinoma; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy Dosage; Retrospective Studies; Taxoids; Young Adult | 2012 |
Adenocarcinoma ex pleomorphic adenoma of the head and neck: Report of five cases.
Topics: Adenoma, Pleomorphic; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Organoplatinum Compounds; Palate; Parotid Gland; Retrospective Studies; Taxoids | 2006 |
The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Radiotherapy, Adjuvant; Retrospective Studies; Taxoids; Young Adult | 2008 |